Table 4 Demographic and clinical characteristics of patients enrolled in this study. Data are shown as mean ± standard deviation or n (%).

From: Comparative validation of AI and non-AI methods in MRI volumetry to diagnose Parkinsonian syndromes

 

PD (\(n=105\))

PSP (\(n=69\))

MSA-P (\(n=63\))

MSA-C (\(n=69\))

Normal (\(n=105\))

Age (years)

\(69.83\pm 10.14\)

\(73.86\pm 7.85\)

\(71.58\pm 9.30\)

\(64.6\pm 9.04\)

\(68.29\pm 9.69\)

Sex (male)

\(56\;(53.33)\)

\(45\;(65.22)\)

\(46\;(66.67)\)

\(31\;(49.21)\)

\(52\;(49.52)\)

Onset to MRI (years)

\(6.02\pm 6.09\)

\(4.68\pm 3.34\)

\(4.27\pm 2.82\)

\(3.01\pm 2.63\)

  1. PD Parkinson’s disease, PSP progressive supranuclear palsy, MSA-P multiple systemic atrophy-Parkinsonian type, MSA-C multiple systemic atrophy-cerebellar type.